About NeuroStarNeuroStar is the established leader in transcranial magnetic stimulation (TMS) therapy, a non-invasive form of neuromodulation. It is backed by the largest clinical data set for MDD of any TMS Therapy. NeuroStar is the #1 physician-preferred TMS treatment for patients with MDD.
CEO: Chris Thatcher
CFO: Mark R. Bausinger
CMO: Mark A. Demitrack
4 articles with NeuroStar
Leading TMS provider joins forces with key thought leaders to destigmatize mental health
Roadblocks To Treatment For People Suffering From Depression Continue To Be Lifted With Next Generation NeuroStar